123 related articles for article (PubMed ID: 29440268)
1. Differentiation of pathologic/neoplastic hypercortisolism (Cushing syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as Pseudo-Cushing syndrome): response to Letter to the Editor.
Findling JW; Raff H
Eur J Endocrinol; 2018 Mar; 178(3):L3. PubMed ID: 29440268
[No Abstract] [Full Text] [Related]
2. Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome): Letter to the Editor.
Thomson M
Eur J Endocrinol; 2018 Mar; 178(3):L1-L2. PubMed ID: 29440267
[No Abstract] [Full Text] [Related]
3. [Depression and intermittent hypercortisolism: a difficult differential diagnostic process].
Zaman E; Van de Velde N; Snauwaert P; Lapauw B; Lemmens G
Tijdschr Psychiatr; 2022; 64(7):466-469. PubMed ID: 36040092
[TBL] [Abstract][Full Text] [Related]
4. Cushing's disease without hypercortisolism.
Dexter RN; Orth DN; Abe K; Nicholson WE; Liddle GW
J Clin Endocrinol Metab; 1970 May; 30(5):573-9. PubMed ID: 4315478
[No Abstract] [Full Text] [Related]
5. Morning plasma free cortisol: inability to distinguish patients with mild Cushing syndrome from patients with pseudo-Cushing states.
Friedman TC; Yanovski JA
J Endocrinol Invest; 1995 Oct; 18(9):696-701. PubMed ID: 8719300
[TBL] [Abstract][Full Text] [Related]
6. Towards a universally accepted definition of subclinical Cushing's syndrome - subclinical autonomous hypercortisolism.
Inder WJ
Clin Endocrinol (Oxf); 2017 Jan; 86(1):7-9. PubMed ID: 27662258
[No Abstract] [Full Text] [Related]
7. Hypercortisolism in the Brain, a Highly Dynamic Process With Stable and Detrimental Consequences.
Meszaros K; Patocs A
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32195542
[No Abstract] [Full Text] [Related]
8. Cushing syndrome: update on testing.
Raff H
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):43-50. PubMed ID: 25732641
[TBL] [Abstract][Full Text] [Related]
9. The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").
Chabre O
Ann Endocrinol (Paris); 2018 Jun; 79(3):138-145. PubMed ID: 29716734
[TBL] [Abstract][Full Text] [Related]
10. Reassessing the reliability of the salivary cortisol assay for the diagnosis of Cushing syndrome.
Zhang Q; Dou J; Gu W; Yang G; Lu J
J Int Med Res; 2013 Oct; 41(5):1387-94. PubMed ID: 24065452
[TBL] [Abstract][Full Text] [Related]
11. [Partial remission of hypercortisolism in Cushing disease after pituitary apoplexy. A case report].
Araya V; Solís I; Lemp M; Oviedo S
Rev Med Chil; 1998 Dec; 126(12):1497-501. PubMed ID: 10349165
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of Cushing syndrome from functional adrenal adenoma and Addison disease from immune-mediated adrenalitis.
Colucci R; Jimenez RE; Farrar W; Malgor R; Kohn L; Schwartz FL
J Am Osteopath Assoc; 2012 Jun; 112(6):374-9. PubMed ID: 22707647
[TBL] [Abstract][Full Text] [Related]
13. What is the best approach to suspected cyclical Cushing syndrome? Strategies for managing Cushing's syndrome with variable laboratory data.
Atkinson B; Mullan KR
Clin Endocrinol (Oxf); 2011 Jul; 75(1):27-30. PubMed ID: 21521302
[TBL] [Abstract][Full Text] [Related]
14. [Passage of cortisol in unaltered and unconjugated form into the urine in central type of Cushing's syndrome and in Addison's disease at different levels of ACTH in the organism].
Pinsker P; Bultasová H
Cas Lek Cesk; 1970 Jan; 109(4):88-92. PubMed ID: 4312783
[No Abstract] [Full Text] [Related]
15. The biochemical investigation of Cushing syndrome.
Simard M
Neurosurg Focus; 2004 Apr; 16(4):E4. PubMed ID: 15191333
[TBL] [Abstract][Full Text] [Related]
16. The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.
Guarnotta V; Amato MC; Pivonello R; Arnaldi G; Ciresi A; Trementino L; Citarrella R; Iacuaniello D; Michetti G; Simeoli C; Colao A; Giordano C
Endocrine; 2017 Feb; 55(2):564-572. PubMed ID: 26965912
[TBL] [Abstract][Full Text] [Related]
17. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N
Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.
Prete A; Paragliola RM; Bottiglieri F; Rota CA; Pontecorvi A; Salvatori R; Corsello SM
Endocrine; 2017 Mar; 55(3):969-980. PubMed ID: 27395418
[TBL] [Abstract][Full Text] [Related]
19. [Measurement of dialyzable cortisol: reflection of cortisol unbound to plasma proteins (preliminary results)].
Lesaffre J; Racadot A; Marchandise X; Lefebvre J; Linquette M
Lille Med; 1974 Feb; 19(2):101-9. PubMed ID: 4849145
[No Abstract] [Full Text] [Related]
20. Do the diagnostic criteria for subclinical hypercortisolism exist?
Tabarin A
Ann Endocrinol (Paris); 2018 Jun; 79(3):146-148. PubMed ID: 29661471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
